TRIM16 Acts as an E3 Ubiquitin Ligase and Can Heterodimerize with Other TRIM Family Members
Jessica L. Bell(UNSW Sydney), Belamy B. Cheung(Children's Cancer Institute Australia)
Cited by 115
Related Papers
Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
|Cellular and Molecular Life Sciences|2012|805
TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells
|Oncogene|2010|70
High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients
|Cancer Letters|2016|64